Toby Maher, MD, PhD, discusses how idiopathic pulmonary fibrosis (IPF) is a specific form of interstitial lung disease characterized by progressive lung scarring, which leads to significant ...
A new SPECT/CT imaging approach can accurately differentiate inflammation from fibrosis in interstitial lung disease (ILD) ...
Panelists discuss how idiopathic pulmonary fibrosis (IPF), a progressive and often fatal interstitial lung disease, presents significant clinical challenges due to its variable trajectory, limited ...
NASHVILLE, Tenn. and CAMBRIDGE, England, May 13, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company with development efforts focused on new ...
The Brighterside of News on MSN
Scientists discover why deadly lung scarring from IPF refuses to heal
Every breath depends on millions of tiny air sacs inside the lungs working smoothly. In people with idiopathic pulmonary ...
STOCKHOLM, SE AND CAMBRIDGE, MA / ACCESS Newswire / June 2, 2026 / Vicore Pharma Holding AB (STO:VICO), unlocking the potential of a novel class of drugs, angiotensin II type 2 (AT2) receptor agonists ...
With IPF, the lungs have a harder time delivering oxygen, and symptoms like shortness of breath and fatigue can make certain aspects of travel more challenging. Planning for oxygen needs and taking ...
Idiopathic pulmonary fibrosis stands as one of medicine’s most challenging respiratory conditions, gradually transforming healthy lung tissue into stiff, scarred material that severely compromises ...
When breathing becomes increasingly difficult with no clear explanation, idiopathic pulmonary fibrosis (IPF) might be the culprit behind the concerning symptoms. This rare yet devastating lung disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results